Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous lactate effects on brain lactate and pH during euglycemia and hypoglycemia in type 1 diabetes
NL-OMON43132Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Nov 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of lactate in diabetes mellitus type 1 (T1D) (2 arms), sponsored by Radboud University Medical Center. Primary endpoints: Change in brain lactate concentration during hypoglycemia with lactate infusion versus placebo in NAH and Difference in brain lactate handling during hypoglycemia between NAH and IAH with lactate infusion. Started Nov 2016; status: active, not recruiting.
02
Drugs
lactate
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on NL-OMON43132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43132.